{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T18:12:11Z","timestamp":1792606331614,"version":"4.5.0"},"reference-count":69,"publisher":"Rockefeller University Press","issue":"10","license":[{"start":{"date-parts":[[2024,9,5]],"date-time":"2024-09-05T00:00:00Z","timestamp":1725494400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.rupress.org\/terms\/"},{"start":{"date-parts":[[2025,3,6]],"date-time":"2025-03-06T00:00:00Z","timestamp":1741219200000},"content-version":"vor","delay-in-days":182,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-sa\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Disease","doi-asserted-by":"publisher","award":["UM1 AI068614"],"award-info":[{"award-number":["UM1 AI068614"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Disease","doi-asserted-by":"publisher","award":["UM1 AI068635"],"award-info":[{"award-number":["UM1 AI068635"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Disease","doi-asserted-by":"publisher","award":["UM1 AI068618"],"award-info":[{"award-number":["UM1 AI068618"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Disease","doi-asserted-by":"publisher","award":["UM1 AI069481"],"award-info":[{"award-number":["UM1 AI069481"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Disease","doi-asserted-by":"publisher","award":["AI110657 HIVRAD"],"award-info":[{"award-number":["AI110657 HIVRAD"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000865","name":"Gates Foundation","doi-asserted-by":"publisher","award":["OPP1107954"],"award-info":[{"award-number":["OPP1107954"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000865","name":"Gates Foundation","doi-asserted-by":"publisher","award":["OPP1147661"],"award-info":[{"award-number":["OPP1147661"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000865","name":"Gates Foundation","doi-asserted-by":"publisher","award":["INV-002022"],"award-info":[{"award-number":["INV-002022"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000865","name":"Gates Foundation","doi-asserted-by":"publisher","award":["INV-002916"],"award-info":[{"award-number":["INV-002916"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["rupress.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,10,7]]},"abstract":"<jats:p>Stabilized trimers preserving the native-like HIV envelope structure may be key components of a preventive HIV vaccine regimen to induce broadly neutralizing antibodies (bnAbs). We evaluated trimeric BG505 SOSIP.664 gp140 formulated with a novel TLR7\/8 signaling adjuvant, 3M-052-AF\/Alum, for safety, adjuvant dose-finding, and immunogenicity in a first-in-healthy adult (n = 17), randomized, and placebo-controlled trial (HVTN 137A). The vaccine regimen appeared safe. Robust, trimer-specific antibody, and B cell and CD4+ T cell responses emerged after vaccination. Five vaccinees developed serum autologous tier 2 nAbs (ID50 titer, 1:28-1:8647) after two to three doses targeting C3\/V5 and\/or V1\/V2\/V3 Env regions by electron microscopy and mutated pseudovirus-based neutralization analyses. Trimer-specific, B cell\u2013derived monoclonal antibody activities confirmed these results and showed weak heterologous neutralization in the strongest responder. Our findings demonstrate the clinical utility of the 3M-052-AF\/Alum adjuvant and support further improvements of trimer-based Env immunogens to focus responses on multiple broad nAb epitopes.<\/jats:p>","DOI":"10.1084\/jem.20240604","type":"journal-article","created":{"date-parts":[[2024,8,17]],"date-time":"2024-08-17T02:20:47Z","timestamp":1723861247000},"update-policy":"https:\/\/doi.org\/10.1084\/jem.crossmarkpolicy","source":"Crossref","is-referenced-by-count":36,"title":["Use of 3M-052-AF with Alum adjuvant in HIV trimer vaccine induces human autologous neutralizing antibodies"],"prefix":"10.1084","volume":"221","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4613-0586","authenticated-orcid":true,"given":"William O.","family":"Hahn","sequence":"first","affiliation":[{"id":[{"id":"https:\/\/ror.org\/007ps6h72","id-type":"ROR","asserted-by":"publisher"}],"name":"Fred Hutchinson Cancer Center 1 Vaccine and Infectious Disease Division, , Seattle, WA, USA"},{"id":[{"id":"https:\/\/ror.org\/03ymk3103","id-type":"ROR","asserted-by":"publisher"}],"name":"University of Washington 11 Department of Medicine, , Seattle, WA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5307-4455","authenticated-orcid":true,"given":"K. Rachael","family":"Parks","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/007ps6h72","id-type":"ROR","asserted-by":"publisher"}],"name":"Fred Hutchinson Cancer Center 1 Vaccine and Infectious Disease Division, , Seattle, WA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9714-8076","authenticated-orcid":true,"given":"Mingchao","family":"Shen","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/007ps6h72","id-type":"ROR","asserted-by":"publisher"}],"name":"Fred Hutchinson Cancer Center 1 Vaccine and Infectious Disease Division, , Seattle, WA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9695-8138","authenticated-orcid":true,"given":"Gabriel","family":"Ozorowski","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/02dxx6824","id-type":"ROR","asserted-by":"publisher"}],"name":"The Scripps Research Institute 2 Department of Integrative Structural and Computational Biology, , La Jolla, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3237-984X","authenticated-orcid":true,"given":"Holly","family":"Janes","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/007ps6h72","id-type":"ROR","asserted-by":"publisher"}],"name":"Fred Hutchinson Cancer Center 1 Vaccine and Infectious Disease Division, , Seattle, WA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6180-5545","authenticated-orcid":true,"given":"Lamar","family":"Ballweber-Fleming","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/007ps6h72","id-type":"ROR","asserted-by":"publisher"}],"name":"Fred Hutchinson Cancer Center 1 Vaccine and Infectious Disease Division, , Seattle, WA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6901-8271","authenticated-orcid":true,"given":"Amanda S.","family":"Woodward Davis","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/007ps6h72","id-type":"ROR","asserted-by":"publisher"}],"name":"Fred Hutchinson Cancer Center 1 Vaccine and Infectious Disease Division, , Seattle, WA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3489-0913","authenticated-orcid":true,"given":"Chris","family":"Duplessis","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/043z4tv69","id-type":"ROR","asserted-by":"publisher"}],"name":"National Institute of Allergy and Infectious Diseases 3 Division of AIDS, , Bethesda, MD, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6362-9151","authenticated-orcid":true,"given":"Mark","family":"Tomai","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/00mgss748","id-type":"ROR","asserted-by":"publisher"}],"name":"3M Healthcare 4 , St. Paul, MD, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7438-9379","authenticated-orcid":true,"given":"Antu K.","family":"Dey","sequence":"additional","affiliation":[{"name":"International AIDS Vaccine Initiative 5 , New York, NY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-9846-211X","authenticated-orcid":true,"given":"Zachary K.","family":"Sagawa","sequence":"additional","affiliation":[{"name":"Access to Advanced Health Institute 6 , Seattle, WA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3871-4618","authenticated-orcid":true,"given":"Stephen C.","family":"De Rosa","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/007ps6h72","id-type":"ROR","asserted-by":"publisher"}],"name":"Fred Hutchinson Cancer Center 1 Vaccine and Infectious Disease Division, , Seattle, WA, USA"},{"name":"University of Washington 7 Department of Laboratory Medicine and Pathology, , Seattle, WA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5877-6229","authenticated-orcid":true,"given":"Aaron","family":"Seese","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/007ps6h72","id-type":"ROR","asserted-by":"publisher"}],"name":"Fred Hutchinson Cancer Center 1 Vaccine and Infectious Disease Division, , Seattle, WA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-4998-3913","authenticated-orcid":true,"given":"Latha","family":"Kallur Siddaramaiah","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/007ps6h72","id-type":"ROR","asserted-by":"publisher"}],"name":"Fred Hutchinson Cancer Center 1 Vaccine and Infectious Disease Division, , Seattle, WA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1106-7097","authenticated-orcid":true,"given":"Leonidas","family":"Stamatatos","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/007ps6h72","id-type":"ROR","asserted-by":"publisher"}],"name":"Fred Hutchinson Cancer Center 1 Vaccine and Infectious Disease Division, , Seattle, WA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9445-6671","authenticated-orcid":true,"given":"Wen-Hsin","family":"Lee","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/02dxx6824","id-type":"ROR","asserted-by":"publisher"}],"name":"The Scripps Research Institute 2 Department of Integrative Structural and Computational Biology, , La Jolla, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2020-2991","authenticated-orcid":true,"given":"Leigh M.","family":"Sewall","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/02dxx6824","id-type":"ROR","asserted-by":"publisher"}],"name":"The Scripps Research Institute 2 Department of Integrative Structural and Computational Biology, , La Jolla, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-1786-905X","authenticated-orcid":true,"given":"Dalton","family":"Karlinsey","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/02dxx6824","id-type":"ROR","asserted-by":"publisher"}],"name":"The Scripps Research Institute 2 Department of Integrative Structural and Computational Biology, , La Jolla, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4745-8057","authenticated-orcid":true,"given":"Hannah L.","family":"Turner","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/02dxx6824","id-type":"ROR","asserted-by":"publisher"}],"name":"The Scripps Research Institute 2 Department of Integrative Structural and Computational Biology, , La Jolla, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2134-0576","authenticated-orcid":true,"given":"Vanessa","family":"Rubin","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/007ps6h72","id-type":"ROR","asserted-by":"publisher"}],"name":"Fred Hutchinson Cancer Center 1 Vaccine and Infectious Disease Division, , Seattle, WA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5181-4651","authenticated-orcid":true,"given":"Sarah","family":"Furth","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/007ps6h72","id-type":"ROR","asserted-by":"publisher"}],"name":"Fred Hutchinson Cancer Center 1 Vaccine and Infectious Disease Division, , Seattle, WA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-0993-4009","authenticated-orcid":true,"given":"Kellie","family":"MacPhee","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/007ps6h72","id-type":"ROR","asserted-by":"publisher"}],"name":"Fred Hutchinson Cancer Center 1 Vaccine and Infectious Disease Division, , Seattle, WA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-4279-0756","authenticated-orcid":true,"given":"Michael","family":"Duff","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/007ps6h72","id-type":"ROR","asserted-by":"publisher"}],"name":"Fred Hutchinson Cancer Center 1 Vaccine and Infectious Disease Division, , Seattle, WA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2179-2436","authenticated-orcid":true,"given":"Lawrence","family":"Corey","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/007ps6h72","id-type":"ROR","asserted-by":"publisher"}],"name":"Fred Hutchinson Cancer Center 1 Vaccine and Infectious Disease Division, , Seattle, WA, USA"},{"name":"University of Washington 7 Department of Laboratory Medicine and Pathology, , Seattle, WA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9048-3621","authenticated-orcid":true,"given":"Michael C.","family":"Keefer","sequence":"additional","affiliation":[{"name":"University of Rochester 8 Department of Medicine, , Rochester, NY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6566-9969","authenticated-orcid":true,"given":"Srilatha","family":"Edupuganti","sequence":"additional","affiliation":[{"name":"Emory University School of Medicine 9 Division of Infectious Diseases, Department of Medicine, , Atlanta, GA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7824-0106","authenticated-orcid":true,"given":"Ian","family":"Frank","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/00b30xv10","id-type":"ROR","asserted-by":"publisher"}],"name":"School of Medicine, University of Pennsylvania 10 , Philadelphia, PA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3992-4193","authenticated-orcid":true,"given":"Janine","family":"Maenza","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/007ps6h72","id-type":"ROR","asserted-by":"publisher"}],"name":"Fred Hutchinson Cancer Center 1 Vaccine and Infectious Disease Division, , Seattle, WA, USA"},{"id":[{"id":"https:\/\/ror.org\/03ymk3103","id-type":"ROR","asserted-by":"publisher"}],"name":"University of Washington 11 Department of Medicine, , Seattle, WA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-1752-1926","authenticated-orcid":true,"given":"Lindsey R.","family":"Baden","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/04b6nzv94","id-type":"ROR","asserted-by":"publisher"}],"name":"Brigham and Women\u2019s Hospital 12 , Boston, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1909-2542","authenticated-orcid":true,"given":"Ollivier","family":"Hyrien","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/007ps6h72","id-type":"ROR","asserted-by":"publisher"}],"name":"Fred Hutchinson Cancer Center 1 Vaccine and Infectious Disease Division, , Seattle, WA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2324-8573","authenticated-orcid":true,"given":"Rogier W.","family":"Sanders","sequence":"additional","affiliation":[{"name":"Academic Medical Center, University of Amsterdam 13 Department of Medical Microbiology, , Amsterdam, Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9902-6096","authenticated-orcid":true,"given":"John P.","family":"Moore","sequence":"additional","affiliation":[{"name":"Weill Medical College of Cornell University 14 Department of Microbiology and Immunology, , New York, NY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7153-3769","authenticated-orcid":true,"given":"Andrew B.","family":"Ward","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/02dxx6824","id-type":"ROR","asserted-by":"publisher"}],"name":"The Scripps Research Institute 2 Department of Integrative Structural and Computational Biology, , La Jolla, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8076-1931","authenticated-orcid":true,"given":"Georgia D.","family":"Tomaras","sequence":"additional","affiliation":[{"name":"Duke University School of Medicine 15 Center for Human Systems Immunology and Departments of Surgery and Integrative Immunobiology, , Durham, NC, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0856-6319","authenticated-orcid":true,"given":"David C.","family":"Montefiori","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/00py81415","id-type":"ROR","asserted-by":"publisher"}],"name":"Duke University 16 Department of Surgery, , Durham, NC, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2512-7919","authenticated-orcid":true,"given":"Nadine","family":"Rouphael","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/03czfpz43","id-type":"ROR","asserted-by":"publisher"}],"name":"Hope Clinic, Emory University 17 , Atlanta, GA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2276-7117","authenticated-orcid":true,"given":"M. Juliana","family":"McElrath","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/007ps6h72","id-type":"ROR","asserted-by":"publisher"}],"name":"Fred Hutchinson Cancer Center 1 Vaccine and Infectious Disease Division, , Seattle, WA, USA"},{"id":[{"id":"https:\/\/ror.org\/03ymk3103","id-type":"ROR","asserted-by":"publisher"}],"name":"University of Washington 11 Department of Medicine, , Seattle, WA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"291","published-online":{"date-parts":[[2024,9,5]]},"reference":[{"key":"2024090513440553000_bib1","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1111\/imr.12861","article-title":"Factors in B cell competition and immunodominance","volume":"296","author":"Abbott","year":"2020","journal-title":"Immunol. Rev."},{"key":"2024090513440553000_bib2","doi-asserted-by":"publisher","first-page":"4817","DOI":"10.1038\/s41467-021-25087-4","article-title":"Polyclonal antibody responses to HIV Env immunogens resolved using cryoEM","volume":"12","author":"Antanasijevic","year":"2021","journal-title":"Nat. Commun."},{"key":"2024090513440553000_bib3","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0022365","article-title":"High-resolution description of antibody heavy-chain repertoires in humans","volume":"6","author":"Arnaout","year":"2011","journal-title":"PLoS One"},{"key":"2024090513440553000_bib4","doi-asserted-by":"publisher","first-page":"2485","DOI":"10.1056\/nejmc2115597","article-title":"Phase 3 Trial of mRNA-1273 during the Delta-Variant Surge","volume":"385","author":"Baden","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"2024090513440553000_bib5","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1016\/j.immuni.2018.07.009","article-title":"Electron-microscopy-based epitope mapping defines specificities of polyclonal antibodies elicited during HIV-1 BG505 envelope trimer immunization","volume":"49","author":"Bianchi","year":"2018","journal-title":"Immunity"},{"key":"2024090513440553000_bib6","doi-asserted-by":"publisher","first-page":"7066","DOI":"10.1016\/j.vaccine.2021.10.019","article-title":"Reactogenicity within 2 weeks after mRNA COVID-19 vaccines: Findings from the CDC v-safe surveillance system","volume":"39","author":"Chapin-Bardales","year":"2021","journal-title":"Vaccine"},{"key":"2024090513440553000_bib7","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1009257","article-title":"The C3\/465 glycan hole cluster in BG505 HIV-1 envelope is the major neutralizing target involved in preventing mucosal SHIV infection","volume":"17","author":"Charles","year":"2021","journal-title":"PLoS Pathog."},{"key":"2024090513440553000_bib8","doi-asserted-by":"publisher","first-page":"427","DOI":"10.3389\/fimmu.2016.00427","article-title":"Modulation of primary immune response by different vaccine adjuvants","volume":"7","author":"Ciabattini","year":"2016","journal-title":"Front. Immunol."},{"key":"2024090513440553000_bib9","doi-asserted-by":"publisher","first-page":"100354","DOI":"10.1016\/j.xcrm.2021.100354","article-title":"Longitudinal analysis shows durable and broad immune memory after SARS-CoV-2 infection with persisting antibody responses and memory B and T cells","volume":"2","author":"Cohen","year":"2021","journal-title":"Cell Rep. Med."},{"key":"2024090513440553000_bib10","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1056\/nejmoa2031738","article-title":"Two randomized trials of neutralizing antibodies to prevent HIV-1 acquisition","volume":"384","author":"Corey","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"2024090513440553000_bib11","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1517\/14712598.2016.1134481","article-title":"The herpes zoster subunit vaccine","volume":"16","author":"Cunningham","year":"2016","journal-title":"Expert Opin. Biol. Ther."},{"key":"2024090513440553000_bib12","doi-asserted-by":"publisher","first-page":"2489","DOI":"10.1128\/jvi.02853-13","article-title":"Global panel of HIV-1 Env reference strains for standardized assessments of vaccine-elicited neutralizing antibodies","volume":"88","author":"deCamp","year":"2014","journal-title":"J. Virol."},{"key":"2024090513440553000_bib13","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1002\/bit.26498","article-title":"cGMP production and analysis of BG505 SOSIP.664, an extensively glycosylated, trimeric HIV-1 envelope glycoprotein vaccine candidate","volume":"115","author":"Dey","year":"2018","journal-title":"Biotechnol. Bioeng."},{"key":"2024090513440553000_bib14","doi-asserted-by":"publisher","DOI":"10.7554\/elife.64281","article-title":"High-resolution mapping of the neutralizing and binding specificities of polyclonal sera post-HIV Env trimer vaccination","volume":"10","author":"Dingens","year":"2021","journal-title":"Elife"},{"key":"2024090513440553000_bib15","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1093\/biostatistics\/kxt024","article-title":"Mixture models for single-cell assays with applications to vaccine studies","volume":"15","author":"Finak","year":"2014","journal-title":"Biostatistics"},{"key":"2024090513440553000_bib16","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.jconrel.2016.11.011","article-title":"Adsorption of a synthetic TLR7\/8 ligand to aluminum oxyhydroxide for enhanced vaccine adjuvant activity: A formulation approach","volume":"244","author":"Fox","year":"2016","journal-title":"J. Control. Release"},{"key":"2024090513440553000_bib17","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1016\/j.cell.2014.06.022","article-title":"Cooperation of B cell lineages in induction of HIV-1-broadly neutralizing antibodies","volume":"158","author":"Gao","year":"2014","journal-title":"Cell"},{"key":"2024090513440553000_bib18","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1038\/s41591-018-0001-2","article-title":"A single injection of crystallizable fragment domain-modified antibodies elicits durable protection from SHIV infection","volume":"24","author":"Gautam","year":"2018","journal-title":"Nat. Med."},{"key":"2024090513440553000_bib19","doi-asserted-by":"publisher","first-page":"2068","DOI":"10.1002\/eji.200838648","article-title":"Alum adjuvanticity: Unraveling a century old mystery","volume":"38","author":"De Gregorio","year":"2008","journal-title":"Eur. J. Immunol."},{"key":"2024090513440553000_bib20","doi-asserted-by":"publisher","first-page":"3356","DOI":"10.1093\/bioinformatics\/btv359","article-title":"Change-O: A toolkit for analyzing large-scale B cell immunoglobulin repertoire sequencing data","volume":"31","author":"Gupta","year":"2015","journal-title":"Bioinformatics"},{"key":"2024090513440553000_bib21","doi-asserted-by":"publisher","first-page":"6144","DOI":"10.1038\/ncomms7144","article-title":"Antibody potency relates to the ability to recognize the closed, pre-fusion form of HIV Env","volume":"6","author":"Guttman","year":"2015","journal-title":"Nat. Commun."},{"key":"2024090513440553000_bib22","doi-asserted-by":"publisher","first-page":"110561","DOI":"10.1016\/j.celrep.2022.110561","article-title":"Rationally designed immunogens enable immune focusing following SARS-CoV-2 spike imprinting","volume":"38","author":"Hauser","year":"2022","journal-title":"Cell Rep."},{"key":"2024090513440553000_bib23","doi-asserted-by":"publisher","first-page":"2195","DOI":"10.1016\/j.celrep.2016.10.085","article-title":"Direct probing of germinal center responses reveals immunological features and bottlenecks for neutralizing antibody responses to HIV Env trimer","volume":"17","author":"Havenar-Daughton","year":"2016","journal-title":"Cell Rep."},{"key":"2024090513440553000_bib24","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1056\/nejmoa1113425","article-title":"Immune-correlates analysis of an HIV-1 vaccine efficacy trial","volume":"366","author":"Haynes","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"2024090513440553000_bib25","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.jim.2007.03.002","article-title":"Optimization and validation of an 8-color intracellular cytokine staining (ICS) assay to quantify antigen-specific T cells induced by vaccination","volume":"323","author":"Horton","year":"2007","journal-title":"J. Immunol. Methods"},{"key":"2024090513440553000_bib26","doi-asserted-by":"publisher","first-page":"101477","DOI":"10.1016\/j.eclinm.2022.101477","article-title":"Safety and immunogenicity of an HIV-1 prefusion-stabilized envelope trimer (Trimer 4571) vaccine in healthy adults: A first-in-human open-label, randomized, dose-escalation, phase 1 clinical trial","volume":"48","author":"Houser","year":"2022","journal-title":"EClinicalMedicine"},{"key":"2024090513440553000_bib27","doi-asserted-by":"publisher","first-page":"10383","DOI":"10.1128\/jvi.01653-15","article-title":"Murine antibody responses to cleaved soluble HIV-1 envelope trimers are highly restricted in specificity","volume":"89","author":"Hu","year":"2015","journal-title":"J. Virol."},{"key":"2024090513440553000_bib28","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1038\/s41598-020-57764-7","article-title":"Comparisons of the antibody repertoires of a humanized rodent and humans by high throughput sequencing","volume":"10","author":"Joyce","year":"2020","journal-title":"Sci. Rep."},{"key":"2024090513440553000_bib29","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.abb1025","article-title":"3M-052, a synthetic TLR-7\/8 agonist, induces durable HIV-1 envelope-specific plasma cells and humoral immunity in nonhuman primates","volume":"5","author":"Kasturi","year":"2020","journal-title":"Sci. Immunol."},{"key":"2024090513440553000_bib30","doi-asserted-by":"publisher","first-page":"9865","DOI":"10.1128\/jvi.01222-13","article-title":"Structural characterization of cleaved, soluble HIV-1 envelope glycoprotein trimers","volume":"87","author":"Khayat","year":"2013","journal-title":"J. Virol."},{"key":"2024090513440553000_bib31","doi-asserted-by":"publisher","first-page":"9873","DOI":"10.1128\/jvi.01226-13","article-title":"Influences on trimerization and aggregation of soluble, cleaved HIV-1 SOSIP envelope glycoprotein","volume":"87","author":"Klasse","year":"2013","journal-title":"J. Virol."},{"key":"2024090513440553000_bib32","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1006913","article-title":"Epitopes for neutralizing antibodies induced by HIV-1 envelope glycoprotein BG505 SOSIP trimers in rabbits and macaques","volume":"14","author":"Klasse","year":"2018","journal-title":"PLoS Pathog."},{"key":"2024090513440553000_bib33","doi-asserted-by":"publisher","first-page":"19570","DOI":"10.1038\/srep19570","article-title":"Different human vaccine adjuvants promote distinct antigen-independent immunological signatures tailored to different pathogens","volume":"6","author":"Knudsen","year":"2016","journal-title":"Sci. Rep."},{"key":"2024090513440553000_bib34","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.1038\/s41467-017-01549-6","article-title":"Structure-based design of native-like HIV-1 envelope trimers to silence non-neutralizing epitopes and eliminate CD4 binding","volume":"8","author":"Kulp","year":"2017","journal-title":"Nat. Commun."},{"key":"2024090513440553000_bib35","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1038\/s41590-023-01510-4","article-title":"CD4+ T cell memory","volume":"24","author":"K\u00fcnzli","year":"2023","journal-title":"Nat. Immunol."},{"key":"2024090513440553000_bib36","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1038\/nsmb.3051","article-title":"Crystal structure, conformational fixation and entry-related interactions of mature ligand-free HIV-1 Env","volume":"22","author":"Kwon","year":"2015","journal-title":"Nat. Struct. Mol. Biol."},{"key":"2024090513440553000_bib37","doi-asserted-by":"publisher","first-page":"101428","DOI":"10.1016\/j.smim.2020.101428","article-title":"Antibody-guided structure-based vaccines","volume":"50","author":"Kwong","year":"2020","journal-title":"Semin. Immunol."},{"key":"2024090513440553000_bib38","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20201254","article-title":"Modulating the quantity of HIV Env-specific CD4 T cell help promotes rare B cell responses in germinal centers","volume":"218","author":"Lee","year":"2021","journal-title":"J. Exp. Med."},{"key":"2024090513440553000_bib39","doi-asserted-by":"publisher","first-page":"22","DOI":"10.3389\/fimmu.2014.00022","article-title":"Immunoglobulin and T Cell receptor genes: IMGT(\u00ae) and the birth and rise of immunoinformatics","volume":"5","author":"Lefranc","year":"2014","journal-title":"Front. Immunol."},{"key":"2024090513440553000_bib40","doi-asserted-by":"publisher","first-page":"D413","DOI":"10.1093\/nar\/gku1056","article-title":"IMGT\u00ae, the international ImMunoGeneTics information system\u00ae 25 years on","volume":"43","author":"Lefranc","year":"2015","journal-title":"Nucleic Acids Res."},{"key":"2024090513440553000_bib41","doi-asserted-by":"publisher","first-page":"gkab1136","DOI":"10.1093\/nar\/gkab1136","article-title":"IMGT\u00ae databases, related tools and web resources through three main axes of research and development","volume":"50","author":"Manso","year":"2021","journal-title":"Nucleic Acids Res."},{"key":"2024090513440553000_bib42","doi-asserted-by":"publisher","first-page":"2327","DOI":"10.1016\/j.celrep.2016.07.074","article-title":"Holes in the glycan shield of the native HIV envelope are a target of trimer-elicited neutralizing antibodies","volume":"16","author":"McCoy","year":"2016","journal-title":"Cell Rep."},{"key":"2024090513440553000_bib43","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1011469","article-title":"Neutralization profiles of HIV-1 viruses from the VRC01 antibody mediated prevention (AMP) trials","volume":"19","author":"Mkhize","year":"2023","journal-title":"PLoS Pathog."},{"key":"2024090513440553000_bib44","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1007\/978-1-59745-170-3_26","article-title":"Measuring HIV neutralization in a luciferase reporter gene assay","volume":"485","author":"Montefiori","year":"2009","journal-title":"Methods Mol. Biol."},{"key":"2024090513440553000_bib45","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1097\/coh.0000000000000442","article-title":"Neutralization tiers of HIV-1","volume":"13","author":"Montefiori","year":"2018","journal-title":"Curr. Opin. HIV AIDS"},{"key":"2024090513440553000_bib46","doi-asserted-by":"publisher","first-page":"2099","DOI":"10.1038\/s41467-022-29356-8","article-title":"Normalizing and denoising protein expression data from droplet-based single cell profiling","volume":"13","author":"Mul\u00e8","year":"2022","journal-title":"Nat. Commun."},{"key":"2024090513440553000_bib47","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.coi.2013.12.007","article-title":"Immunomodulatory properties of the vaccine adjuvant alum","volume":"28","author":"Oleszycka","year":"2014","journal-title":"Curr. Opin. Immunol."},{"key":"2024090513440553000_bib48","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1038\/nature13808","article-title":"Structure and immune recognition of trimeric pre-fusion HIV-1 Env","volume":"514","author":"Pancera","year":"2014","journal-title":"Nature"},{"key":"2024090513440553000_bib49","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1016\/j.immuni.2017.05.007","article-title":"Elicitation of robust tier 2 neutralizing antibody responses in nonhuman primates by HIV envelope trimer immunization using optimized approaches","volume":"46","author":"Pauthner","year":"2017","journal-title":"Immunity"},{"key":"2024090513440553000_bib50","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.immuni.2018.11.011","article-title":"Vaccine-induced protection from homologous tier 2 SHIV challenge in nonhuman primates depends on serum-neutralizing antibody titers","volume":"50","author":"Pauthner","year":"2019","journal-title":"Immunity"},{"key":"2024090513440553000_bib51","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1111\/imr.12481","article-title":"Native-like Env trimers as a platform for HIV-1 vaccine design","volume":"275","author":"Sanders","year":"2017","journal-title":"Immunol. Rev."},{"key":"2024090513440553000_bib52","doi-asserted-by":"publisher","first-page":"aac4223","DOI":"10.1126\/science.aac4223","article-title":"HIV-1 VACCINES. HIV-1 neutralizing antibodies induced by native-like envelope trimers","volume":"349","author":"Sanders","year":"2015","journal-title":"Science"},{"key":"2024090513440553000_bib53","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.jim.2013.11.022","article-title":"Optimization and validation of the TZM-bl assay for standardized assessments of neutralizing antibodies against HIV-1","volume":"409","author":"Sarzotti-Kelsoe","year":"2014","journal-title":"J. Immunol. Methods"},{"key":"2024090513440553000_bib54","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.abo5598","article-title":"Stabilized HIV-1 envelope immunization induces neutralizing antibodies to the CD4bs and protects macaques against mucosal infection","volume":"14","author":"Saunders","year":"2022","journal-title":"Sci. Transl. Med."},{"key":"2024090513440553000_bib55","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1009736","article-title":"Antibody responses induced by SHIV infection are more focused than those induced by soluble native HIV-1 envelope trimers in non-human primates","volume":"17","author":"van Schooten","year":"2021","journal-title":"PLoS Pathog."},{"key":"2024090513440553000_bib56","doi-asserted-by":"publisher","first-page":"5434","DOI":"10.1016\/j.vaccine.2011.05.061","article-title":"Vaccine adjuvant activity of 3M-052: An imidazoquinoline designed for local activity without systemic cytokine induction","volume":"29","author":"Smirnov","year":"2011","journal-title":"Vaccine"},{"key":"2024090513440553000_bib57","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1038\/nature23301","article-title":"Rapid elicitation of broadly neutralizing antibodies to HIV by immunization in cows","volume":"548","author":"Sok","year":"2017","journal-title":"Nature"},{"key":"2024090513440553000_bib58","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1186\/s13059-018-1603-1","article-title":"Cell Hashing with barcoded antibodies enables multiplexing and doublet detection for single cell genomics","volume":"19","author":"Stoeckius","year":"2018","journal-title":"Genome Biol."},{"key":"2024090513440553000_bib59","doi-asserted-by":"publisher","first-page":"1702","DOI":"10.1016\/j.cell.2015.11.056","article-title":"Immunogenicity of stabilized HIV-1 envelope trimers with reduced exposure of non-neutralizing epitopes","volume":"163","author":"de Taeye","year":"2015","journal-title":"Cell"},{"key":"2024090513440553000_bib60","doi-asserted-by":"publisher","first-page":"1856","DOI":"10.1016\/j.immuni.2022.07.020","article-title":"Antibodies from primary humoral responses modulate the recruitment of naive B cells during secondary responses","volume":"55","author":"Tas","year":"2022","journal-title":"Immunity"},{"key":"2024090513440553000_bib61","doi-asserted-by":"publisher","first-page":"12449","DOI":"10.1128\/jvi.01708-08","article-title":"Initial B-cell responses to transmitted human immunodeficiency virus type 1: Virion-binding immunoglobulin M (IgM) and IgG antibodies followed by plasma anti-gp41 antibodies with ineffective control of initial viremia","volume":"82","author":"Tomaras","year":"2008","journal-title":"J. Virol."},{"key":"2024090513440553000_bib62","doi-asserted-by":"publisher","first-page":"5233","DOI":"10.1038\/s41598-019-41695-z","article-title":"From louvain to leiden: Guaranteeing well-connected communities","volume":"9","author":"Traag","year":"2019","journal-title":"Sci. Rep."},{"key":"2024090513440553000_bib63","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abh2791","article-title":"Disassembly of HIV envelope glycoprotein trimer immunogens is driven by antibodies elicited via immunization","volume":"7","author":"Turner","year":"2021","journal-title":"Sci. Adv."},{"key":"2024090513440553000_bib64","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1111\/imr.12507","article-title":"The HIV-1 envelope glycoprotein structure: Nailing down a moving target","volume":"275","author":"Ward","year":"2017","journal-title":"Immunol. Rev."},{"key":"2024090513440553000_bib65","doi-asserted-by":"publisher","first-page":"E2083","DOI":"10.1073\/pnas.1208984109","article-title":"Structural basis for germ-line gene usage of a potent class of antibodies targeting the CD4-binding site of HIV-1 gp120","volume":"109","author":"West","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2024090513440553000_bib66","doi-asserted-by":"publisher","first-page":"1686","DOI":"10.21105\/joss.01686","article-title":"Welcome to the tidyverse","volume":"4","author":"Wickham","year":"2019","journal-title":"J. Open Source Softw."},{"key":"2024090513440553000_bib67","doi-asserted-by":"publisher","first-page":"228ra39","DOI":"10.1126\/scitranslmed.3007730","article-title":"Vaccine-induced Env V1-V2 IgG3 correlates with lower HIV-1 infection risk and declines soon after vaccination","volume":"6","author":"Yates","year":"2014","journal-title":"Sci. Transl. Med."},{"key":"2024090513440553000_bib68","doi-asserted-by":"publisher","first-page":"108122","DOI":"10.1016\/j.celrep.2020.108122","article-title":"Mapping neutralizing antibody epitope specificities to an HIV Env trimer in immunized and in infected rhesus macaques","volume":"32","author":"Zhao","year":"2020","journal-title":"Cell Rep."},{"key":"2024090513440553000_bib69","doi-asserted-by":"publisher","DOI":"10.7554\/elife.42166","article-title":"New tools for automated high-resolution cryo-EM structure determination in RELION-3","volume":"7","author":"Zivanov","year":"2018","journal-title":"Elife"}],"container-title":["Journal of Experimental Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/rupress.org\/jem\/article-pdf\/doi\/10.1084\/jem.20240604\/1932223\/jem_20240604.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/rupress.org\/jem\/article-pdf\/doi\/10.1084\/jem.20240604\/1932223\/jem_20240604.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,5]],"date-time":"2024-09-05T09:44:39Z","timestamp":1725529479000},"score":1,"resource":{"primary":{"URL":"https:\/\/rupress.org\/jem\/article\/221\/10\/e20240604\/276955\/Use-of-3M-052-AF-with-Alum-adjuvant-in-HIV-trimer"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,5]]},"references-count":69,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2024,10,7]]}},"URL":"https:\/\/doi.org\/10.1084\/jem.20240604","relation":{},"ISSN":["0022-1007","1540-9538"],"issn-type":[{"value":"0022-1007","type":"print"},{"value":"1540-9538","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,5]]},"article-number":"e20240604"}}